An "Anti-Beta-Galactosidase antibody" typically targets the enzyme protein (GLB1). Our service develops "Anti-?-Gal antibodies" that target the carbohydrate structure (the sugar epitope) itself, regardless of which protein it is attached to. This is crucial for studying glycosylation patterns rather than just protein expression.
